熱門資訊> 正文

Aytu BioPharma SEARCH 4 2025年盈利预览

2025-09-23 05:35

Aytu BioPharma (NASDAQ:AYTU) is scheduled to announce FQ4 earnings results on Tuesday, September 23rd, after market close.
The consensus EPS Estimate is -$0.06 and the consensus Revenue Estimate is $17.92M.

More on Aytu BioPharma

FDA targets drug marketing, advertising with slew of warning letters
Seeking Alpha’s Quant Rating on Aytu BioPharma
Historical earnings data for Aytu BioPharma
Financial information for Aytu BioPharma

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。